Global Emerging Pathogen Treatment Consortium Formed To Study Potential Of Immune Plasma Treatment In The Fight Against Ebola
African-led Group of Clinicians, Blood Banks and Social Science Experts, in Collaboration with U.S.-based Clinical RM and United States Army Medical Research Institute of Infectious Diseases, Work to Identify a Better Understanding and Solutions to Ebola Outbreak

HINCKLEY, Ohio, Nov. 19, 2014 /PRNewswire/ — An African-led scientific team in collaboration with U.S.-based Clinical Research Management, Inc. (ClinicalRM), and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced the assembly of the Global Emerging Pathogens Therapy/Treatment (GET) Consortium.

This group of medical and project management experts from all the geopolitical regions of Africa, Europe, Asia and the United States, is pooling resources to assess the efficacy of immune plasma collected from survivors of Ebola Virus Disease (EVD) in West Africa. The Consortium, whose plan is closely aligned with the WHO position paper on collection and use of convalescent plasma or serum as an element in Filovirus outbreak response, expects to begin clinical trials in November 2014. Members from the GET Consortium are also acting as key scientific advisors for the effort in West Africa related to convalescent plasma for the treatment of Ebola virus disease recently announced by the Bill & Melinda Gates Foundation…